Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma

NCT03042429 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT03042429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma
Lead sponsor
University of Cologne
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2007
Completion date
December 31, 2016
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma